Pleomorphic Hyalinizing Angiectatic Tumor of Renal Hilum
Overview
Affiliations
Pleomorphic hyalinizing angiectatic tumor (PHAT) is a recently described rare entity. The tumor histogenesis is proposed to be of primitive undifferentiated mesenchyme. The tumor has a predilection for the subcutaneous soft tissue especially of lower extremity, although other locations have been well documented. We report a case of PHAT arising in the hilum of the kidney, clinically mimicking an infiltrating malignant neoplasm of renal pelvis. The tumor was discovered during workup for unrelated gastrointestinal tract symptoms. Because of the location of the lesion, excision of mass and radical nephrectomy were performed. The tumor had strong immunohistochemical expression of vimentin, CD34, CD99, and vascular endothelial growth factor (VEGF). No additional lesions were documented during 3 years of follow-up. This is consistent with the current thinking that PHAT is a benign neoplasm with increased incidence of recurrence. We document the unique retroperitoneal location of this rare tumor and suggest that PHAT should be considered among the list of unusual lesions at this site.
Salehipour M, Anbardar M, Geramizadeh B, Jafari H, Zare A, Adib A Rare Tumors. 2022; 14:20363613221103751.
PMID: 35651782 PMC: 9150221. DOI: 10.1177/20363613221103751.
da Silva E, Abreu R, Nascimento A, de Brot Andrade L Autops Case Rep. 2022; 12:e2021353.
PMID: 35252046 PMC: 8893159. DOI: 10.4322/acr.2021.353.
Pleomorphic Hyalinizing Angiectatic Tumor (PHAT): Review of the Literature with Case Presentation.
Cazzato G, Colagrande A, Cimmino A, Lettini T, Savino M, Martella C Dermatopathology (Basel). 2021; 8(2):97-102.
PMID: 33916538 PMC: 8167509. DOI: 10.3390/dermatopathology8020015.
Pleomorphic hyalinizing angiectatic tumor of the mesorectum: a rare case and review of literature.
Balasubiramaniyan V, Muduly D, Samal S, Kar M, Sultania M, Patra S Autops Case Rep. 2019; 9(3):e2019097.
PMID: 31440480 PMC: 6655857. DOI: 10.4322/acr.2019.097.
Jaramillo C, Wojcik J, Weber K, Sebro R Oncol Lett. 2018; 15(4):4720-4730.
PMID: 29552111 PMC: 5840667. DOI: 10.3892/ol.2018.7929.